APA (7th ed.) Citation

S, R., K, A., J, K., & JL, H. (2023, February). Review of Tolerability of Fremanezumab for Episodic and Chronic Migraine. Neuropsychiatric Disease and Treatment.

Chicago Style (17th ed.) Citation

S, Root, Ahn K, Kirsch J, and Hoskin JL. "Review of Tolerability of Fremanezumab for Episodic and Chronic Migraine." Neuropsychiatric Disease and Treatment Feb. 2023.

MLA (9th ed.) Citation

S, Root, et al. "Review of Tolerability of Fremanezumab for Episodic and Chronic Migraine." Neuropsychiatric Disease and Treatment, Feb. 2023.